Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.

被引：21
|
作者：
Lugtenburg, Pieternella J.
Brown, Peter de Nully
van der Holt, Bronno
D'Amore, Francesco
Koene, Harry R.
Berenschot, Henriette W.
Fijnheer, Rob
Loosveld, Olaf
Bohmer, Lara H.
Pruijt, Hans
Verhoef, Gregor
Hoogendoorn, Mels
de Kan, Romko
Van Imhoff, Gustaaf Willem
van Hooije, Christel
Lam, King H.
de Keizer, Bart
de Jong, Daphne
Hoekstra, Otto S.
Zijlstra, Josee M.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7504
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
    Park, Steven I.
    Richards, Kristy L.
    Asch, Adam S.
    Olajide, Oludamilola
    Deal, Allison M.
    Ivanova, Anastasia
    Wall, James G.
    Sobol, Anna L.
    Foster, Matthew C.
    Muss, Hyman B.
    Shea, Thomas C.
    BLOOD, 2013, 122 (21)
  • [42] A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma
    Wagner-Johnston, Nina D.
    Goy, Andre
    Rodriguez, Maria A.
    Ehmann, W. Christopher
    Hamlin, Paul A.
    Radford, John
    Thieblemont, Catherine
    Suh, Cheolwon
    Sweetenham, John
    Huang, Yifan
    Sullivan, Sharon T.
    Vandendries, Erik R.
    Gisselbrecht, Christian
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2863 - 2869
  • [43] Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP
    Kang, Hye Jin
    Kim, Won Seog
    Suh, Cheolwon
    Park, Yeon Hee
    Kim, Bong Seog
    Yuh, Young Jin
    Ryoo, Baek-Yeol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 299 - 304
  • [44] Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP
    Hye Jin Kang
    Won Seog Kim
    Cheolwon Suh
    Yeon Hee Park
    Bong Seog Kim
    Young Jin Yuh
    Baek-Yeol Ryoo
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 299 - 304
  • [45] Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium
    Hainsworth, John D.
    Flinn, Ian W.
    Spigel, David R.
    Clark, Bobby L.
    Griner, Paula L.
    Vazquez, Elizabeth R.
    Doss, Habib H.
    Shipley, Dianna
    Franco, Luis A.
    Burris, Howard A., III
    Greco, F. Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01): : 44 - 50
  • [46] Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma
    Nastoupil, Loretta J.
    Kuruvilla, John
    Chavez, Julio C.
    Bijou, Fontanet
    Witzig, Thomas E.
    Santoro, Armando
    Flinn, Ian W.
    Boccomini, Carola
    Kenkre, Vaishalee P.
    Corradini, Paolo
    Isufi, Iris
    Andorsky, David J.
    Klein, Leonard M.
    Greenwald, Daniel R.
    Sangha, Randeep
    Shen, Frank
    Hagner, Patrick
    Li, Yan
    Dobmeyer, Juergen
    Gong, Nian
    Uttamsingh, Shailaja
    Pourdehnad, Michael
    Ribrag, Vincent
    EJHAEM, 2022, 3 (02): : 394 - 405
  • [47] Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Won Seog
    Lee, Won-Sik
    Do, Young Rok
    Oh, Sung Yong
    Kim, Min Kyoung
    Mun, Yeung-Chul
    Shin, Ho-Jin
    Kwak, Jae-Yong
    Kang, Hye Jin
    Won, Jong Ho
    Kwon, Jung Hye
    Park, Eunkyung
    Suh, Cheolwon
    Yang, Deok-Hwan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (06) : 504 - 510
  • [48] A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
    Shi, Yuankai
    Song, Yongping
    Qin, Yan
    Zhang, Qingyuan
    Han, Xiaohong
    Hong, Xiaonan
    Wang, Dong
    Li, Wei
    Zhang, Yang
    Feng, Jifeng
    Yang, Jianmin
    Zhang, Huilai
    Jin, Chuan
    Yang, Yu
    Hu, Jianda
    Wang, Zhao
    Jin, Zhengming
    Su, Hang
    Wang, Huaqing
    Yang, Haiyan
    Fu, Weijun
    Zhang, Mingzhi
    Zhang, Xiaohong
    Chen, Yun
    Ke, Xiaoyan
    Liu, Li
    Yu, Ding
    Chen, Guo'an
    Wang, Xiuli
    Jin, Jie
    Sun, Tao
    Du, Xin
    Cheng, Ying
    Yi, Pingyong
    Zhao, Xielan
    Ma, Chaoming
    Cheng, Jiancheng
    Chai, Katherine
    Luk, Alvin
    Liu, Eugene
    Zhang, Xin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [49] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Stefoni, Vittorio
    Quirini, Federica
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Baccarani, Michele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06): : 462 - 466
  • [50] A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
    Yuankai Shi
    Yongping Song
    Yan Qin
    Qingyuan Zhang
    Xiaohong Han
    Xiaonan Hong
    Dong Wang
    Wei Li
    Yang Zhang
    Jifeng Feng
    Jianmin Yang
    Huilai Zhang
    Chuan Jin
    Yu Yang
    Jianda Hu
    Zhao Wang
    Zhengming Jin
    Hang Su
    Huaqing Wang
    Haiyan Yang
    Weijun Fu
    Mingzhi Zhang
    Xiaohong Zhang
    Yun Chen
    Xiaoyan Ke
    Li Liu
    Ding Yu
    Guo’an Chen
    Xiuli Wang
    Jie Jin
    Tao Sun
    Xin Du
    Ying Cheng
    Pingyong Yi
    Xielan Zhao
    Chaoming Ma
    Jiancheng Cheng
    Katherine Chai
    Alvin Luk
    Eugene Liu
    Xin Zhang
    Journal of Hematology & Oncology, 13
12345